Circulating miRNAs Respond to Denosumab Treatment after Two Years in Postmenopausal Women with Osteoporosis. Messner Z, Carro-Vazquez D, Haschka J, Grillari J, et al. J Clin Endocrinol Metab 2022 Nov 19:dgac667. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Messner Z, Carro-Vazquez D, Haschka J, Grillari J, et al. Circulating miRNAs Respond to Denosumab Treatment after Two Years in Postmenopausal Women with Osteoporosis. J Clin Endocrinol Metab 2022 Nov 19:dgac667. doi: 10.1210.
PMID: 36408612